cifenline has been researched along with Cardiac Remodeling, Ventricular in 3 studies
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, M | 3 |
| Shigematsu, Y | 3 |
| Ikeda, S | 3 |
| Ohshima, K | 2 |
| Ogimoto, A | 2 |
| Nakamura, M | 1 |
| Kubota, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy-- a Multicenter Randomized Control Trial[NCT02948998] | Phase 4 | 260 participants (Anticipated) | Interventional | 2018-05-14 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cifenline and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Advances in medical treatment of hypertrophic cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Calcium Channel Blocke | 2014 |
2 other studies available for cifenline and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Impact of cibenzoline treatment on left ventricular remodelling and prognosis in hypertrophic obstructive cardiomyopathy.
Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Humans; Imidazoles; Prognosis; Ventricular Rem | 2021 |
Impact of chronic use of cibenzoline on left ventricular pressure gradient and left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy.
Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiography; F | 2016 |